Puma Biotechnology Inc (PBYI)
5.195
+0.10
(+1.86%)
USD |
NASDAQ |
Apr 17, 16:00
5.195
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Cash from Investing (TTM): -19.12M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -19.12M |
September 30, 2023 | -22.83M |
June 30, 2023 | -26.01M |
March 31, 2023 | -19.33M |
December 31, 2022 | 7.104M |
September 30, 2022 | 23.60M |
June 30, 2022 | 11.13M |
March 31, 2022 | 3.402M |
December 31, 2021 | -10.88M |
September 30, 2021 | -4.679M |
June 30, 2021 | -2.787M |
March 31, 2021 | -6.275M |
December 31, 2020 | 33.40M |
September 30, 2020 | 22.15M |
June 30, 2020 | 63.70M |
March 31, 2020 | 84.12M |
December 31, 2019 | 5.163M |
September 30, 2019 | 8.177M |
June 30, 2019 | -52.16M |
March 31, 2019 | -102.17M |
December 31, 2018 | -57.62M |
September 30, 2018 | -83.72M |
June 30, 2018 | -18.29M |
March 31, 2018 | 38.60M |
December 31, 2017 | -15.44M |
Date | Value |
---|---|
September 30, 2017 | 28.92M |
June 30, 2017 | 14.31M |
March 31, 2017 | 6.66M |
December 31, 2016 | 142.19M |
September 30, 2016 | 161.03M |
June 30, 2016 | 126.82M |
March 31, 2016 | 48.28M |
December 31, 2015 | -85.86M |
September 30, 2015 | -103.34M |
June 30, 2015 | -101.37M |
March 31, 2015 | -123.90M |
December 31, 2014 | -63.28M |
September 30, 2014 | -82.19M |
June 30, 2014 | -77.19M |
March 31, 2014 | -6.309M |
December 31, 2013 | -41.53M |
September 30, 2013 | -45.21M |
June 30, 2013 | -47.45M |
March 31, 2013 | -28.08M |
December 31, 2012 | -1.221M |
September 30, 2012 | -2.575M |
June 30, 2012 | -2.564M |
March 31, 2012 | -2.17M |
December 31, 2011 | -1.746M |
September 30, 2011 | -0.0034M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-52.16M
Minimum
Jun 2019
84.12M
Maximum
Mar 2020
5.152M
Average
3.402M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
ADMA Biologics Inc | -4.981M |
Regeneron Pharmaceuticals Inc | -3.185B |
CytomX Therapeutics Inc | -150.67M |
Sarepta Therapeutics Inc | -165.80M |
Mirum Pharmaceuticals Inc | -107.20M |